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Abstract
Background: Heterotopic ossification (HO) is a complication after tissue trauma, fracture and surgery (i.e. total hip
arthroplasty). Prophylaxis is the most effective therapy. If HO formations become symptomatic and limit patients’
quality of life, revision surgery is indicated and is usually combined with a perioperative oral prophylaxis (NSAIDs)
and/or irradiation. However, a long-term use of NSAIDs can induce gastro-intestinal or cardiac side-effects and
possible bony non-unions during fracture healing. Subject of this study was to assess the current status of
HO prophylaxis after injuries or fractures and to evaluate current indications and strategies for excision of
symptomatic HO.
Methods: Between 2013 and 2014, a questionnaire was sent to 119 orthopaedic and trauma surgery
departments in Germany. Participation was voluntary and all acquired data was given anonymously.
Results: The cumulative feedback rate was 71 %. Trauma and orthopaedic surgery departments in Germany
recommend oral HO prophylaxis after acetabulum and femoral neck fractures, elbow dislocation, and fracture
or dislocation of the radial head. Pain upon movement and an increasing loss of range of motion in the
affected joint are considered to be clear indications for HO surgery. A partial removal of ROM-limiting HO
formations was also considered important. The vast majority of all departments include perioperative oral HO
prophylaxis and/or irradiation if surgical HO removal is planned. The choice and duration of NSAIDs is
highly variable.
Conclusion: HO is of clinical significance in current traumatology and orthopaedics. Certain fractures and
injuries are prone to HO, and prophylactic measures should be taken. The respondents in this survey assessed current
therapeutic strategies for HO formations similarly. These concepts are in line with the literature. However, the duration of
perioperative oral HO prophylaxis varied greatly among the specialist centres. This is significant as a long-term use of
NSAIDs fosters a potential risk for the patients’ safety and could influence the clinical outcome. National and
international guidelines need to be developed to further reduce HO rates and improve patients’ safety in
trauma and orthopaedic surgery.
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Background
Heterotopic ossification (HO) can occur after tissue
trauma (i.e. gunshot wounds), cerebral and spinal cord
injury, bone fractures or surgery such as total hip arthro-
plasty (THA) [1, 2]. The pathogenesis of HO is not fully
understood.
An effective HO prophylaxis requires identifying
known risk factors in the patient, using gentle surgical
techniques and applying perioperative non-steroidal anti
rheumatic drugs (NSAIDs), COX-2 blockers and low-
dose irradiation [2]. This is well established for THA.
Little is known about the significance of HO prophylaxis
in blunt extremity trauma and fracture treatment.
Nevertheless, some studies have suggested that NSAIDs,
which suppress inflammatory prostaglandins during ini-
tial tissue inflammation, could cause delayed fracture
healing in animals [3, 4]. Large and symptomatic HO
formations can only be treated surgically [5]. However,
revision surgery itself can induce a HO relapse.
Historically, Germany had a separation of trauma and
orthopaedic surgery departments. Consequently, differ-
ent therapy strategies evolved in both fields. Several
years ago this separation was, however, revoked and a
single residency program was created. Nonetheless, dif-
ferences still remain in both disciplines.
The intention of this study was to investigate the fol-
lowing questions:
1. Is HO clinically relevant?
2. Are HO-prone injuries assessed in a similar manner
in different specialist centres?
3. Are there standard HO prophylactic measures after
fractures and tissue trauma?
4. What are the current indications and strategies for
surgical HO removal if HO formations limit
patients’ quality of life?
Methods
After a current literature review, the authors developed
a questionnaire. The 17 questions aimed to assess
prophylactic and therapeutic strategies for heterotopic
ossification in orthopaedic and trauma surgery. Indica-
tions for surgery and surgical techniques were graded on
a 4-point scale (insignificant, of little importance, im-
portant or very important).
The study was carried out from 2013 to 2014 in 34
orthopaedic and 30 trauma surgery departments in
German university hospitals. When there were separate
departments in the same hospital, both departments
were addressed. Furthermore, we contacted 55 German
hospitals that had been granted a certificate (EndoCert®) for
high standards in THA from the German Association of
Orthopaedic Surgery and were listed on the official home-
page until January 9th 2014. The study participants were
trained orthopaedic/trauma surgeons, not patients. The re-
spondents agreed to participate voluntarily in this trial by
sending back the completed questionnaire in an anonym-
ous fashion. Therefore, an informed consent was waived.
The collected data included estimations, therapy assess-
ments or ratings and did not allow any conclusion about
the participants’ identity. An approval by the local IRB was
waived according to the guideline for Good Clinical Prac-
tice and the Declaration of Helsinki as this trial did not in-
volve the collection of sensitive data from humans.
Statistical analysis
Statistics were generated with Microsoft Excel 2008.
Statistics used for this study were descriptive only as several
answers to the questions included estimations from the
questionnaire recipients. Hence, standard parameters such
as mean, median, maximum and minimum were detected,
but no statistical analysis for significance was performed.
Results
The total response rate was 71 % (85 of 119). The feed-
back rate was 76 % (42 of 55) among non-university hos-
pitals, 67 % (20 of 30) in trauma and 68 % (23 of 34) in
the orthopaedic departments of university hospitals.
The majority of surgeons offer a regular radiological
follow-up that enables a realistic assessment of the
course of treatment. Most respondents assessed HO-
prone injuries in a similar manner and therefore recom-
mend an oral HO prophylaxis after certain fractures (see
Table 1 for details).
The indications for HO excision were assessed simi-
larly. Pain at rest, pain during joint movement and a re-
duced range of motion (ROM) are considered important
or very important. Thirty-seven percent of the respon-
dents found a skeleton scintigraphy to be useful. The
evaluation of surgical strategy and techniques for HO
excision were moderately different among orthopaedic
and trauma surgeons (see Table 2 for details).
In HO excision, the majority of surgeons change their
HO prophylactic strategy by applying irradiation and/or
administering a different NSAID. The choice of medica-
tion and the amount of time it was taken were inconsist-
ent. Irradiation is usually planned pre-operatively in
Germany (see Table 3 for details).
Discussion
In recent years, strategies for HO in total hip arthroplasty
have been discussed in various studies [6]. A national treat-
ment guideline in Germany (2009) recommends NSAID
use for HO prophylaxis after THA and elbow injuries/sur-
gery [7]. No recommendation was given for fractures, tissue
trauma and spinal or cerebral injuries. Fracture osteosynth-
esis and manipulation of soft tissue and joints seem to be
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HO risk factors [8, 9]. Gunshot or blast injuries can also
cause HO formations [10].
The aim of this study was to evaluate current prophy-
lactic strategies after injuries and to analyse therapeutic
concepts of symptomatic HO. Additionally, we intended
to investigate whether data taken from recent literature
had found its way into daily trauma and orthopaedic
practice. However, this review has certain limitations.
Surveys usually cannot provide strong evidence of cause
and effect. Future studies could include face to face
follow-up visits for patients who were treated for HO,
since the subjective error from patients is hard to re-
move. Secondly, the survey included closed questions,
which are generally considered to be of lesser validity
than open-ended questions, which were also included.
Ultimately, the results of this study are limited by re-
sponse rate and the subjective estimations from the re-
spondents. The response rate was 71 % (85/119), which
is considered high [11, 12].
A main finding of this study is that orthopaedic and
trauma surgeons alike consider HO to be clinically rele-
vant after certain fractures and injuries. Nevertheless,
there are differences in current HO prophylaxis. Trauma
surgery departments have a higher rate of HO prophy-
laxis after risk fractures/injuries compared to ortho-
paedic university departments and non-university
EndoCert® hospitals. The oral HO prophylaxis duration
was also slightly higher among trauma surgeons, but on
average for three weeks post trauma.
The literature provides numerous clinical trials which
found that an oral HO prophylaxis (indomethacin) can
reduce the incidence of large HO formations (Brooker
grades 3 and 4) after certain fractures [13]. It must be
taken into account that NSAIDs can lead to delayed frac-
ture healing and non-unions in animals [3, 4]. Despite
these results, many patients receive NSAIDs for both, post-
operative pain and anti-inflammatory (HO prophylactic)
treatment after trauma. An evidence- based recommenda-
tion for the most effective drug and perioperative applica-
tion time for oral HO prophylaxis is currently missing
from the literature.
The respondents in this study mostly considered ace-
tabular fractures, elbow dislocation, femoral neck and
shaft fractures and radial head dislocation or fracture to
be most prone to HO. Current literature supports this
assessment. A recent retrospective study (2013) found a
47 % incidence of HO (56 of 120 patients) after surgery
for acetabular fracture [14]. After elbow fracture surgery
involving the proximal radius and/or ulna, HO was re-
ported in 37 % of cases (48 of 142) [15]. Johansson et al.
analysed femoral neck fracture treatment (THA vs. in-
ternal fixation): Seventy-one percent (32 of 45) of hips
with THA developed HO compared to 2.5 % (1 of 39) in
the internal fixation group [16]. Mechanical ventilation
time, indomethacin and incidence of head injuries did
not differ between the two groups. Plate osteosynthesis
seems to create a higher risk for HO formation than
intramedullary nailing in multiple trauma patients [17].
A possible explanation might be that plate osteosynth-
esis is often used for intraarticular fracture treatment
and could induce higher muscle injuries, whereas intra-
medullary nailing is mostly used for diaphysal fractures.
Another risk factor for HO formation in multiple trauma
patients is brain injury. A higher rate of HO is found
Table 1 HO prophylaxis in fracture treatment and summary of injuries and fracture types that are prone to HO formation according
to respondents; HO = heterotopic ossification; AC = acromio-clavicular; min. = minimum, max. =maximum
Germany
University (trauma) University (orthopaedic) Non-university hospitals Total
Feed back rate 67 % (n = 20 of 30) 68 % (n = 23 of 34) 76 % (n = 42 of 55) 71 % (n = 85 of 119)
HO prophylaxis for risk fractures 79 % 67 % 59 % 67 %
Mean time of prophylaxis (days) 25 (min. 14 – max. 42) 17 (min. 7 – max. 42) 21 (min.7 – max.84) 21 (min. 7 – max. 84)
Regular radiological follow-up 85 % 96 % 67 % 79 %
Injuries and fractures prone to HO:
Acetabulum fracture 79 % 52 % 38 % 54 %
Elbow dislocation 42 % 24 % 31 % 32 %
Radial head dislocation 16 % 5 % 10 % 10 %
Radial head fracture 21 % 14 % 10 % 14 %
Femoral neck fracture 11 % 48 % 31 % 30 %
Femoral shaft fracture 0 % 24 % 17 % 14 %
Clavicula fracture 0 % 5 % 7 % 4 %
AC joint injury 0 % 5 % 7 % 4 %
Other 0 % 0 % 0 % 0 %
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Table 2 Indication and techniques for surgical HO removal; HO = heterotopic ossification
Germany
University (trauma) University (orthopaedic) Non-university hospitals Total
Indications for surgery
Pain at rest
Insignificant 10 % 0 % 0 % 3 %
Of little importance 40 % 17 % 22 % 25 %
Important 35 % 57 % 67 % 55 %
Very important 15 % 26 % 11 % 17 %
Pain during joint movement
Insignificant 0 % 0 % 0 % 0 %
Of little importance 11 % 0 % 0 % 3 %
Important 53 % 64 % 69 % 64 %
Very important 37 % 36 % 31 % 33 %
Reduced ROM of affected joint
Insignificant 0 % 0 % 0 % 0 %
Of little importance 5 % 9 % 3 % 5 %
Important 20 % 43 % 56 % 43 %
Very important 75 % 48 % 41 % 52 %
Increase of HO formation
Insignificant 16 % 13 % 14 % 14 %
Of little importance 26 % 39 % 36 % 34 %
Important 42 % 44 % 28 % 37 %
Very important 16 % 4 % 22 % 14 %
Active HO formation in scintigraphy
Insignificant 21 % 4 % 14 % 13 %
Of little importance 63 % 61 % 39 % 50 %
Important 16 % 26 % 33 % 28 %
Very important 0 % 9 % 14 % 9 %
Techniques of surgical excision
Complete excision of HO formation
Insignificant 5 % 0 % 3 % 3 %
Of little importance 40 % 36 % 30 % 34 %
Important 45 % 55 % 53 % 51 %
Very important 10 % 9 % 14 % 12 %
Excision of ROM-limiting HO
Insignificant 5 % 0 % 2 % 3 %
Of little importance 15 % 30 % 23 % 22 %
Important 30 % 48 % 46 % 43 %
Very important 50 % 22 % 29 % 32 %
Tissue interposition after HO removal
Insignificant 45 % 13 % 25 % 27 %
Of little importance 40 % 70 % 61 % 60 %
Important 10 % 17 % 14 % 13 %
Very important 5 % 0 % 0 % 0 %
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when serious brain injury occurred and there was a need
for mechanical ventilation [18].
If HO formations increase, they can cause postoperative
pain, bony impingement with impaired range of motion of
the affected joints, leading ultimately to revision surgery.
This survey shows that current indications and strategies
for surgical HO removal are similar with trauma and ortho-
paedic surgeons. Surgical removal of HO is complicated as
the formations are often soft and integrated in the muscle
or connective tissue. Some studies demonstrated that exci-
sion of HO can lead to a significantly improved ROM, but
pain can often not be minimized [19]. Salazar et al. [20] de-
scribed a significant, postoperative improvement in ROM
after resection of HOs following elbow fractures when pre-
operative ROM was partially or completely restricted. Con-
sequently surgeons should carefully consider these results
from the literature when HO excision is indicated. At this
stage, there is limited data as to whether HO formations
should be removed completely or partially.
If revision surgery is indicated, the vast majority of
surgeons combine irradiation and an oral prophylaxis in
their therapy regimen. However, this review has found
that there are still vast differences in the choice of drug
and the perioperative application time (minimum 7 days,
maximum 98 days). A majority of trauma surgeons pre-
fer the use of indomethacin in HO surgery.
An evidence-based recommendation for the most ef-
fective HO prophylaxis (type of drug, application time)
following HO excision is still missing in the current lit-
erature. The combination of irradiation and NSAID use
for HO treatment of various joints has been successfully
described [21]. The outcome of irradiation does not
seem to increase the risk of malignancy [22].
There are few alternative or new treatment options for
HO: The long-term effect of bisphosphonates to prevent
HO remains unclear [23]. Basic research found selective
retinoic acid receptor γ (RAR γ) agonists able to sup-
press BMP signalling and chondrogenesis in a murine
model [24]. Inhibitors of substance P and mast cell
blockers (cromolyn) showed significant reduction in HO
rates in animals and seem to be promising future thera-
peutics [25]. The use of RNAi might become an add-
itional new alternative [26]. These options are currently
at an experimental stage but could become available in
the near future to further reduce HO rates in ortho-
paedic and trauma surgery.
Conclusion
This survey indicates that orthopaedic and trauma sur-
geons in Germany consider HO to be of clinical relevance
in their daily practice. The injuries that are at risk of HO
and require HO prophylaxis were usually assessed in a
Table 3 Perioperative irradiation and oral HO prophylaxis; HO = heterotopic ossification; Gy = Gray
Germany
University (trauma) University (orthopaedic) Non-university hospitals Total
Postoperative oral HO prophylaxis 100 % 81 % 86 % 88 %
Perioperative irradiation 90 % 96 % 91 % 92 %
Change in prophylaxis strategy 65 % 35 % 31 % 38 %
Diclofenac 0 % 25 % 30 % 17 %
Median dosage per day - 150 mg 150 mg 150 mg
Ibuprofen 11 % 25 % 10 % 13 %
Median dosage per day 1800 mg 1200 mg 1200 mg 1600 mg
Indomethacin 89 % 50 % 30 % 57 %
Median dosage per day 150 mg 150 mg 100 mg 100 mg
Etoricoxib 0 % - 20 % 9 %
Median dosage per day - - 90 mg 90 mg
Celecoxib 0 % - 10 % 4 %
Median dosage per day - - 400 mg 400 mg
Other - - 0 %
Mean time of oral prophylaxis (days) 28 (min.14 – max.42) 42 (min.14 – max.98) 21 (min.7 – max.42) 30 (min.7 – max.98)
Pre-operative irradiation 75 % 86 % 90 % 83 %
Post-operative irradiation 25 % 14 % 10 % 17 %
Times of irradiation 1 1 1 1
Median dosage in Gy 7 7 7 7
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similar manner. Indications for surgery of symptomatic
HO formations and surgical techniques were equally
weighted and are in concordance with the literature. The
perioperative oral prophylaxis (i.e. choice of NSAID or
COX-2 blocker, application duration) which is often com-
bined with revision surgery was highly variable. This is sig-
nificant for clinical practice as a long-term use of NSAIDs
fosters a potential risk to the patients’ safety and could in-
fluence the clinical outcome. This survey was able to dem-
onstrate that in 2014 there was still a need for clinical
trials as well as national and international treatment guide-
lines to detect the most effective HO prophylaxis for risk
fractures/injuries and following HO excision. This could
further reduce HO rates and improve patients’ safety in
trauma and orthopaedic surgery.
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